Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
PLoS One. 2021 Jul 23;16(7):e0255217. doi: 10.1371/journal.pone.0255217. eCollection 2021.
This study aims to describe the prevalence of depression and anxiety among a population sample of people at high risk for type 2 diabetes in Kerala, India, and examine the relationship between depressive symptoms, anxiety, and incident Type 2 Diabetes Mellitus (T2DM) over a two-year period. We used data from the Kerala Diabetes Prevention Program, a cluster-randomized controlled trial for diabetes prevention among 1007 high-risk individuals. The prevalence of depression and anxiety were estimated using the 9-item Patient Health Questionnaire and the Generalized Anxiety Disorder 7-item scale, respectively. We calculated proportions for depression and anxiety and performed generalized estimating equations (GEE) to examine the relationship between baseline mental health status and incident T2DM. The prevalence of depression and anxiety at baseline were 7.5% and 5.5%, respectively. Compared with those reporting none/low symptoms, the odds ratio for incident diabetes was 1.07 (95% CI 0.54-2.12) for participants with moderate to severe depression and 0.73 (95% CI 0.23-2.28) for participants with moderate to severe anxiety, after adjusting for potential confounders. Our findings suggest that the prevalence of depression and anxiety were higher than those previously reported in the general population in India. However, among this sample of community-based adults at high risk of developing T2DM, the presence of moderate to severe depression and/or anxiety symptoms was not significantly associated with the risk of developing T2DM. Trial registration: Australia and New Zealand Clinical Trials Registry ACTRN12611000262909. Registered 10 March 2011.
本研究旨在描述印度喀拉拉邦 2 型糖尿病高危人群中抑郁和焦虑的流行情况,并探讨在两年期间抑郁症状、焦虑与 2 型糖尿病(T2DM)发病之间的关系。我们使用了印度喀拉拉邦糖尿病预防计划的数据,该计划是一项针对 1007 名高危人群的糖尿病预防的集群随机对照试验。使用 9 项患者健康问卷和广泛性焦虑症 7 项量表分别估计抑郁和焦虑的患病率。我们计算了抑郁和焦虑的比例,并使用广义估计方程(GEE)来检验基线心理健康状况与 T2DM 发病之间的关系。基线时抑郁和焦虑的患病率分别为 7.5%和 5.5%。与报告无/低症状的患者相比,中度至重度抑郁患者的 T2DM 发病比值比为 1.07(95%CI 0.54-2.12),中度至重度焦虑患者的比值比为 0.73(95%CI 0.23-2.28),在调整了潜在混杂因素后。我们的研究结果表明,抑郁和焦虑的患病率高于印度一般人群中之前的报告。然而,在这个基于社区的、有发展 T2DM 高危的成年人样本中,中度至重度抑郁和/或焦虑症状的存在与 T2DM 发病风险并无显著关联。试验注册:澳大利亚和新西兰临床试验注册中心 ACTRN12611000262909。注册于 2011 年 3 月 10 日。